BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38695983)

  • 21. Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells.
    Vaapil M; Helczynska K; Villadsen R; Petersen OW; Johansson E; Beckman S; Larsson C; Påhlman S; Jögi A
    PLoS One; 2012; 7(9):e46543. PubMed ID: 23029547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammary stem cells and breast cancer--role of Notch signalling.
    Farnie G; Clarke RB
    Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.
    Communal L; Vilasco M; Hugon-Rodin J; Courtin A; Mourra N; Lahlou N; Le Guillou M; Perrault de Jotemps M; Chauvet MP; Chaouat M; Pujol P; Feunteun J; Delaloge S; Forgez P; Gompel A
    Oncotarget; 2016 Jul; 7(29):45317-45330. PubMed ID: 27246982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
    Lindahl G; Saarinen N; Abrahamsson A; Dabrosin C
    Cancer Res; 2011 Jan; 71(1):51-60. PubMed ID: 21097717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weighing the Risk: effects of Obesity on the Mammary Gland and Breast Cancer Risk.
    Hillers-Ziemer LE; Arendt LM
    J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):115-131. PubMed ID: 32519090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compressive stress-mediated p38 activation required for ERα + phenotype in breast cancer.
    Munne PM; Martikainen L; Räty I; Bertula K; Nonappa ; Ruuska J; Ala-Hongisto H; Peura A; Hollmann B; Euro L; Yavuz K; Patrikainen L; Salmela M; Pokki J; Kivento M; Väänänen J; Suomi T; Nevalaita L; Mutka M; Kovanen P; Leidenius M; Meretoja T; Hukkinen K; Monni O; Pouwels J; Sahu B; Mattson J; Joensuu H; Heikkilä P; Elo LL; Metcalfe C; Junttila MR; Ikkala O; Klefström J
    Nat Commun; 2021 Nov; 12(1):6967. PubMed ID: 34845227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression.
    Martinson HA; Jindal S; Durand-Rougely C; Borges VF; Schedin P
    Int J Cancer; 2015 Apr; 136(8):1803-13. PubMed ID: 25187059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal Gas6 promotes the progression of premalignant mammary cells.
    Gomes AM; Carron EC; Mills KL; Dow AM; Gray Z; Fecca CR; Lakey MA; Carmeliet P; Kittrell F; Medina D; Machado HL
    Oncogene; 2019 Apr; 38(14):2437-2450. PubMed ID: 30531835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
    Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
    PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.
    Jordan VC
    Breast Cancer Res Treat; 1995; 36(3):267-85. PubMed ID: 8573710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast.
    Chollet-Hinton L; Puvanesarajah S; Sandhu R; Kirk EL; Midkiff BR; Ghosh K; Brandt KR; Scott CG; Gierach GL; Sherman ME; Vachon CM; Troester MA
    Mod Pathol; 2018 Jul; 31(7):1085-1096. PubMed ID: 29463881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):827-43, viii-ix. PubMed ID: 16308095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammographic density, MRI background parenchymal enhancement and breast cancer risk.
    Pike MC; Pearce CL
    Ann Oncol; 2013 Nov; 24 Suppl 8(Suppl 8):viii37-viii41. PubMed ID: 24131968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217.
    Northey JJ; Barrett AS; Acerbi I; Hayward MK; Talamantes S; Dean IS; Mouw JK; Ponik SM; Lakins JN; Huang PJ; Wu J; Shi Q; Samson S; Keely PJ; Mukhtar RA; Liphardt JT; Shepherd JA; Hwang ES; Chen YY; Hansen KC; Littlepage LE; Weaver VM
    J Clin Invest; 2020 Nov; 130(11):5721-5737. PubMed ID: 32721948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human breast cancer cells are redirected to mammary epithelial cells upon interaction with the regenerating mammary gland microenvironment in-vivo.
    Bussard KM; Smith GH
    PLoS One; 2012; 7(11):e49221. PubMed ID: 23155468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward a physiological approach to breast cancer prevention.
    Russo J; Russo IH
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):353-64. PubMed ID: 8061586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer.
    Svensson S; Abrahamsson A; Rodriguez GV; Olsson AK; Jensen L; Cao Y; Dabrosin C
    Clin Cancer Res; 2015 Aug; 21(16):3794-805. PubMed ID: 25901081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.